A Knowledge Capital Group perspective on post-merger integration
Every merger announcement makes similar promises: expanded access, stronger margins, and better care. The strategic rationale may be compelling, but delivering on those promises is a different challenge altogether.
A recent PwC survey of 530 senior dealmakers found that only about one in three acquirers fully achieve their deal objectives.1 Integration is also expensive, especially in healthcare. EY found that health care and life sciences integration costs run a median 10.1% of target revenue, the highest of the sectors it analyzed.2 Better care doesn’t follow automatically, either. A study published in the New England Journal of Medicine examining 246 acquired hospitals found that patient experience declined following acquisition, with no significant improvement in readmissions or mortality.3
The challenge isn’t the deal, rather what happens after the deal closes.
The Traditional Playbook Doesn’t Always Fit
Cross-market mergers have become an increasingly prominent part of healthcare consolidation. Transactions such as Northwell’s combination with Nuvance Health, Sanford’s merger with Marshfield Clinic, and BJC’s combination with Saint Luke’s reflect a shift toward organizations operating across distinct geographic markets.4
These transactions introduce a different set of integration challenges.
Traditional integration playbooks often focus on opportunities created by geographic overlap: consolidating service lines, eliminating redundant infrastructure, and combining operations. In cross-market mergers, many of those opportunities simply don’t exist.
Instead, value creation depends on building shared capabilities, improving operating efficiency, aligning leadership and governance, and extending effective practices across markets that have historically operated independently.
Cross-market combinations also bring together organizations with distinct cultures, histories, and ways of working, often without the day-to-day physical proximity that helps teams build trust. In the same PwC survey, more than half of dealmakers named culture alignment as a key people challenge.5 Culture, being the key piece and challenge, is one of the most challenging to get right. Unlike finance, IT, and other functions, it is not something that can be created behind closed doors or in a back office. It has to be deliberately aligned, meticulously thought through, and planned for. This requires more than a traditional integration checklist. It requires a deliberate approach to how the combined organization will operate and how the expected value of the transaction will be realized.
What Separates Results from Expectations
In our experience, the difference between integrations that deliver results and those that fall short often comes down to one thing: whether integration is treated as a dedicated management responsibility or added to the existing workload of executives already running the business.
That distinction sounds simple, but it shows up in specific, observable practices. Across the integrations we’ve supported, five disciplines consistently separate organizations that capture value from those that don’t.
Dedicated leadership with real authority. Integration needs a leader who is accountable for the overall outcome, has the capacity to focus on it, and can escalate issues and drive decisions across functions and cultures. A committee of executives meeting periodically is not a substitute for dedicated leadership.
Ownership of financial and operational targets. Every synergy should have a validated baseline, measurable target, accountable owner, and timeline. Progress needs to be reviewed regularly, with a direct connection to financial results. A list of initiatives is not the same as a credible plan to capture value.
Decision rights established early. The combined organization needs clarity on what will be managed centrally, what will remain local, and who has authority to make decisions. Without this, integration teams can spend months negotiating responsibilities rather than making progress. This becomes particularly important in cross-market mergers, where local market needs may differ significantly.
People and clinical alignment alongside operational integration. Technology platforms, shared services, and back-office processes are important, but they are only part of the equation. Physician engagement, leadership alignment, and organizational culture can determine whether new operating practices actually take hold. These considerations need to be addressed from the outset, not after the technical integration is complete.
A defined path to business-as-usual operations. Integration cannot remain a separate initiative indefinitely. Effective integration offices start with the end in mind and set an end date from the start. As that date approaches, they hand accountability to operational leaders and build new processes and performance expectations into how the organization runs. Without that handoff, progress stalls as executive attention moves elsewhere.
The Discipline Is the Differentiator
We’ve seen the impact of this approach firsthand. KCG led the establishment and operation of an integration management office overseeing three consecutive mergers, delivering more than 200 basis points of margin improvement in 18 months.
The results weren’t driven by a more sophisticated project plan. They came from consistent execution: clear accountability, disciplined performance reviews, timely decisions, and a direct connection between integration activities and financial outcomes.
That is the role of an effective Integration Management Office (IMO). It is not simply a project management function responsible for tracking milestones. It is the management structure that translates the deal thesis into operating and financial results.
For health systems preparing for a merger, the strategic case is usually settled before the deal is announced. The harder question is who owns the value on day one, and whether they have the authority, focus, and discipline to deliver it.
Planning for a merger? Let’s talk.
- PwC, “PwC’s 2026 M&A Integration Survey,” September 29, 2026. Survey of 530 C-suite executives and senior dealmakers at organizations with $1 billion+ in annual revenue. https://www.pwc.com/us/en/services/consulting/deals/library/ma-integration-survey.html
- EY, “Beyond the deal: accurately estimating M&A integration cost,” December 9, 2024. Analysis of deals valued at US$500 million or more, 2010 to 2023. https://www.ey.com/en_us/insights/strategy-transactions/four-current-trends-estimating-mergers-acquisitions-integration-costs
- Beaulieu ND, Dafny LS, Landon BE, Dalton JB, Kuye I, McWilliams JM. “Changes in Quality of Care after Hospital Mergers and Acquisitions.” New England Journal of Medicine. 2020;382(1):51-59. doi:10.1056/NEJMsa1901383
- Transaction closings: BJC HealthCare and Saint Luke’s Health System, January 1, 2024 (BJC press release, January 2, 2024); Sanford Health and Marshfield Clinic Health System, January 2025 (Marshfield Clinic announcement, January 2, 2025); Northwell Health and Nuvance Health, May 2025 (News 12, May 7, 2025).
- PwC, “PwC’s 2026 M&A Integration Survey.” 52% of respondents cited culture alignment as a people challenge.
